Home / RGT.AX : ASX

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does RGT.AX make money? Does RGT.AX have pricing power? What's the Earnings Whisper? Will RGT.AX profit more as the business scales? What is RGT.AX's management track record? Is RGT.AX's current price justified?

Argent BioPharma Limited

AUD 0.03 -$0.05 (-64.79%)

ASX · 30 Oct 2026 02:09 UTC

Previous Close

AUD 0.02

Day Range

AUD 0.02AUD 0.03

Year Range

AUD 0.02AUD 0.11

Market Cap

2.95M

AVG Volume

498.24K

Trailing/Forward PE

-0.23/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

2027-03-03

Primary Exchange

Australian Securities Exchange

Revenue (AUD) · Q

RGT.AX Revenue (AUD) by quarter
Period	Revenue (AUD)
25 Q2	171.5K
25 Q1	85.75K
24 Q4	176.23K
24 Q2	4.28K
23 Q4	291.55K
23 Q2	599.53K
22 Q4	724.92K
22 Q2	2.66M
21 Q4	2.17M
21 Q2	2.58M

Net Income (AUD) · Q

RGT.AX Net Income (AUD) by quarter
Period	Net Income (AUD)
25 Q2	-2.94M
25 Q1	-1.47M
24 Q4	-5.68M
24 Q2	-12.16M
23 Q4	-10.45M
23 Q2	-7.08M
22 Q4	-9.94M
22 Q2	-10.88M
21 Q4	-12.91M
21 Q2	-7.89M

Operating Income (AUD) · Q

RGT.AX Operating Income (AUD) by quarter
Period	Operating Income (AUD)
25 Q2	-2.95M
25 Q1	-1.49M
24 Q4	-7.37M
24 Q2	-8.29M
23 Q4	-11.14M
23 Q2	-6.53M
22 Q4	-7.01M
22 Q2	-6.32M
21 Q4	-7.72M
21 Q2	-4.25M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (AUD) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 3 Mar 2027.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Argent BioPharma Limited

Earnings: RGT.AX

Video analysis: RGT.AX

News: RGT.AX

Similar companies